Skip to content
Governance Register

← US public companies

Denali Therapeutics Inc.

SEC CIK 1714899 · DNLI · last insider filing 2026-06-05

Directors (from insider filings)

NameCapacity as filedFilings
Baker Julian Director filed 2025 - 2026
Baker Felix Director filed 2025 - 2026
Flatley JAY T Director filed 2017 - 2026
Baker Bros. Advisors LP Director filed 2025 - 2026
Baker Brothers Life Sciences LP Director filed 2025 - 2026
Klein Peter S Director filed 2018 - 2026
667, L.P. Director filed 2025 - 2026
Schenkein David P Director filed 2017 - 2026
Baker Bros. Advisors (GP) LLC Director filed 2025 - 2026
Krognes Steve E. Director · CFO and Treasurer filed 2017 - 2026
Cook Jennifer E. Director filed 2018 - 2026
Thornberry Nancy Director filed 2021 - 2026
Van Hauwermeiren Timothy Director filed 2025 - 2026
Watts Ryan J. Director · President and CEO filed 2017 - 2026
Tessier-Lavigne Marc Director filed 2017 - 2025
Sato Vicki L Director filed 2017 - 2025
Harris Erik Director filed 2022 - 2024
Cole Douglas G. Director filed 2017 - 2023
Nelsen Robert Director filed 2017 - 2021

Officers (from insider filings)

NameTitle as filedFilings
Chin Peter Scott Chief Medical Officer filed 2026 - 2026
Schuth Alexander O. COO and Secretary filed 2017 - 2026
Ho Carole Chief Medical Officer filed 2017 - 2025

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.